I am so excited to share our new paper in @Nature: the first programmable, site-specific integration of a large DNA payload into T cells in vivo.
A single IV injection results in therapeutic levels of TRAC-targeted CAR T cells in multiple models.
https://t.co/t3pyjHyGWS
a ๐งต
@kazuki_nozawa@Annals_Oncology This is really interesting! So if I'm understanding correctly, if you have had progression on T-DXd, but some initial response, this may be an option?
@Dr_Oncologista In this case it's mesonephric-like adenocarcinoma, initial response with T-DXd, but keeping an eye on what might be other treatment ideas. Appreciate what you do!